emzolam TEMOZOLOMIDE

Introduction to emzolam

Emzolam is a medication primarily used in the treatment of certain aggressive brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. Emzolam is available in tablet form and is designed to target cancer cells in the brain.

Composition of emzolam

Emzolam contains the active ingredient Temozolomide, which is an alkylating agent. This compound works by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.

Uses of emzolam

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of emzolam

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: low blood cell counts, increased risk of infection

Precautions of emzolam

Patients should be aware that emzolam can lower blood cell counts, increasing the risk of infection. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take emzolam

Emzolam is typically taken orally in tablet form. The usual starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor’s advice for the correct dosage and usage.

Conclusion of emzolam

Emzolam, containing the active ingredient Temozolomide, is a part of the alkylating agents therapeutic class and is primarily used to treat aggressive brain tumors. It is manufactured for oral administration and should be used under medical supervision. Emzolam is effective in targeting cancer cells but requires careful monitoring due to potential side effects and contraindications. Always consult with a healthcare professional before starting treatment with emzolam.